HRM

Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.

Spirochetes of B. mayonii. (Used with permission: Mayo Foundation for Medical Education and Research. All rights reserved.)

The reference lab noted unusual melt temperatures in samples processed for Lyme disease, and collaborated with others to find the spirochete in Upper Midwest ticks.

The startup is looking for a PCR instrument partner for its automated back-end technology for resolving and quantifying multiple nucleic acids from a sample.

Rusinga Island, via Wikimedia Commons.

The new method detects very low levels of parasitemia which could be useful for future malaria erradication efforts.

A team from the University of Potsdam in Germany has combined wild-type blocking PCR using locked nucleic acids with high-resolution melting analysis to detect DNA mutations of unknown type and position in a background of up to 10,000-fold wild-type DNA.

The National Institutes of Health Office of Technology Transfer this month disclosed several new licensing opportunities related to molecular diagnostics using PCR or other nucleic acid amplification and analysis technologies.

Researchers from several institutions have developed a high-resolution melting assay that can provide measurements of HIV diversity that are highly concordant with equivalent sequencing-based measurements at a fraction of the cost.

The FDA in February approved an earlier version of the FilmArray Respiratory Panel, but Idaho Tech chose not to commercialize that product, instead waiting for FDA approval of an updated version including two additional viral targets, the parainfluenza 1 and 2 viruses.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.